Free Trial
OTCMKTS:BICX

BioCorRx (BICX) Stock Price, News & Analysis

BioCorRx logo
$0.36 0.00 (0.00%)
(As of 11/20/2024 ET)

About BioCorRx Stock (OTCMKTS:BICX)

Key Stats

Today's Range
$0.36
$0.36
50-Day Range
$0.30
$0.50
52-Week Range
$0.28
$1.50
Volume
N/A
Average Volume
1,527 shs
Market Capitalization
$4.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Receive BICX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioCorRx and its competitors with MarketBeat's FREE daily newsletter.

BICX Stock News Headlines

Breaking News: Tesla headed to $500…
That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.
See More Headlines

BICX Stock Analysis - Frequently Asked Questions

BioCorRx's stock was trading at $0.78 at the beginning of the year. Since then, BICX shares have decreased by 53.8% and is now trading at $0.36.
View the best growth stocks for 2024 here
.

BioCorRx Inc. (OTCMKTS:BICX) announced its earnings results on Thursday, November, 17th. The company reported ($0.02) earnings per share for the quarter. The business had revenue of $0.17 million for the quarter.

Shares of BICX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioCorRx investors own include PlayAGS (AGS), Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Mondi (MNDI), Assertio (ASRT), Astronics (ATRO) and CONSOL Coal Resources (CCR).

Company Calendar

Last Earnings
11/17/2016
Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Specialty outpatient clinics, not elsewhere classified
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:BICX
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-3,770,000.00
Net Margins
-11,600.00%
Pretax Margin
-18,340.74%

Debt

Sales & Book Value

Annual Sales
$90,000.00
Book Value
($1.14) per share

Miscellaneous

Free Float
10,021,000
Market Cap
$4.59 million
Optionable
Not Optionable
Beta
0.61

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (OTCMKTS:BICX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners